We are live on ! Find out more
CA

Callahan Advisors Portfolio holdings

AUM $1.33B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.38%
1 Year Est. Return
+29.71%
3 Year Est. Return
+87.75%
5 Year Est. Return
+121.89%
10 Year Est. Return
+408.77%
AUM
$573M
AUM Growth
+$15.3M
Cap. Flow
+$5.61M
Cap. Flow %
0.98%
Top 10 Hldgs %
28.59%
Holding
139
New
2
Increased
76
Reduced
36
Closed
5

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$737K
2
T icon
AT&T
T
+$673K
3
BHP icon
BHP
BHP
+$629K
4
ZTS icon
Zoetis
ZTS
+$623K
5
SSNC icon
SS&C Technologies
SSNC
+$602K

Top Sells

Rank Stock Value
1
VIAB
Viacom Inc. Class B
VIAB
+$1.02M
2
CELG
Celgene Corp
CELG
+$772K
3
GIS icon
General Mills
GIS
+$728K
4
PG icon
Procter & Gamble
PG
+$700K
5
EXP icon
Eagle Materials
EXP
+$625K

Sector Composition

Rank Sector Weight
1 Technology 17.82%
2 Financials 15.11%
3 Healthcare 13.47%
4 Communication Services 10.79%
5 Consumer Staples 10.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTAS icon
51
Cintas
CTAS
$81.6B
$3.43M 0.6%
51,228
-620
-1% -$39.7K
WTW icon
52
Willis Towers Watson
WTW
$31.7B
$3.24M 0.57%
16,772
+949
+6% +$185K
SSNC icon
53
SS&C Technologies
SSNC
$18.6B
$3.18M 0.56%
61,748
+11,777
+24% +$602K
STE icon
54
Steris
STE
$22.7B
$2.99M 0.52%
20,711
+896
+5% +$134K
CVS icon
55
CVS Health
CVS
$134B
$2.81M 0.49%
44,612
+12,429
+39% +$737K
TSN icon
56
Tyson Foods
TSN
$21B
$2.81M 0.49%
32,598
+6,154
+23% +$523K
IQV icon
57
IQVIA
IQV
$38.4B
$2.76M 0.48%
18,455
+420
+2% +$65.4K
DFS
58
DELISTED
Discover Financial Services
DFS
$2.43M 0.43%
30,000
– –
KO icon
59
Coca-Cola
KO
$374B
$2.36M 0.41%
43,310
-192
-0.4% -$10.3K
GIS icon
60
General Mills
GIS
$19.2B
$2.27M 0.4%
41,252
-13,512
-25% -$728K
BNS icon
61
Scotiabank
BNS
$108B
$2.25M 0.39%
39,528
+2,606
+7% +$140K
AGN
62
DELISTED
Allergan Inc
AGN
$2.13M 0.37%
12,655
-119
-0.9% -$20K
FISV
63
Fiserv Inc
FISV
$29B
$2.02M 0.35%
19,520
-870
-4% -$88.8K
STEL
64
DELISTED
Stellar Bancorp
STEL
$1.94M 0.34%
69,662
-500
-0.7% -$14.2K
AXP icon
65
American Express
AXP
$233B
$1.94M 0.34%
16,383
+1
+0% +$123
TRI icon
66
Thomson Reuters
TRI
$44.4B
$1.84M 0.32%
26,100
– –
VRSK icon
67
Verisk Analytics
VRSK
$25.1B
$1.77M 0.31%
11,212
+1,088
+11% +$169K
WPP icon
68
WPP
WPP
$4.39B
$1.74M 0.3%
27,810
+2,090
+8% +$125K
BUD
69
DELISTED
ANHEUSER BUSCH COS INC
BUD
$1.74M 0.3%
18,240
-100
-0.5% -$9.52K
ABBV icon
70
AbbVie
ABBV
$433B
$1.69M 0.29%
22,278
+1,100
+5% +$75.4K
LAZ icon
71
Lazard
LAZ
$4.21B
$1.59M 0.28%
45,464
-620
-1% -$22K
THO icon
72
Thor Industries
THO
$4.03B
$1.58M 0.28%
27,906
-2,802
-9% -$147K
ZTS icon
73
Zoetis
ZTS
$32.3B
$1.45M 0.25%
11,610
+5,160
+80% +$623K
V icon
74
Visa
V
$683B
$1.42M 0.25%
8,261
– –
ENB icon
75
Enbridge
ENB
$118B
$1.29M 0.22%
36,662
– –
1 2
3
4 5

Similar funds

SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
HCM
Hilton Capital Management Garden City, New York $1.32B AUM 15.59% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MDSL
M.D. Sass LLC New York $1.32B AUM 16.01% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Callahan Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Callahan Advisors held 139 positions worth $573M, up 2.7% from $557M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Callahan Advisors's Q3 2019 filing shows 2 new, 76 increased, 36 reduced and 5 closed positions. Its largest new stake was Schwab Emerging Markets Equity ETF: 10,020 shares worth $252K. The largest sale was Viacom Inc. Class B, an estimated $1.02M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Callahan Advisors's largest Q3 2019 buy was Schwab Emerging Markets Equity ETF: 10,020 shares worth $252K.
  • Callahan Advisors added most to CVS Health in Q3 2019, an estimated $737K increase.
  • Callahan Advisors's biggest Q3 2019 reduction was Celgene Corp, cutting an estimated $772K.
  • Callahan Advisors fully exited Viacom Inc. Class B in Q3 2019, selling an estimated $1.02M.
  • Callahan Advisors's ten largest holdings make up 29% of its $573M portfolio in Q3 2019.
  • Callahan Advisors opened 2 new positions and closed 5 in Q3 2019.
  • Callahan Advisors's portfolio value rose 2.7% quarter-over-quarter to $573M.

Based on Callahan Advisors's 13F filing for Q3 2019, filed 21 Oct 2019.